COMMUNITY HEALTH SYSTEMS INC (CYH) Stock Fundamental Analysis
NYSE:CYH - New York Stock Exchange, Inc. - US2036681086 - Common Stock - Currency: USD
Taking everything into account, CYH scores 3 out of 10 in our fundamental rating. CYH was compared to 108 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CYH while its profitability can be described as average. CYH has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CYH has reported negative net income.
CYH had a positive operating cash flow in the past year.
In multiple years CYH reported negative net income over the last 5 years.
Of the past 5 years CYH 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.66%, CYH is in line with its industry, outperforming 42.06% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 5.69%, CYH is in the better half of the industry, outperforming 65.42% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CYH is below the industry average of 8.14%.
The 3 year average ROIC (5.27%) for CYH is below the current ROIC(5.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.66% | ||
| ROE | N/A | ||
| ROIC | 5.69% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
1.3 Margins
CYH has a better Operating Margin (6.67%) than 70.09% of its industry peers.
CYH's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 84.60%, CYH belongs to the best of the industry, outperforming 95.33% of the companies in the same industry.
CYH's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.67% | ||
| PM (TTM) | N/A | ||
| GM | 84.6% |
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CYH is destroying value.
CYH has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CYH has been increased compared to 5 years ago.
CYH has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.79, we must say that CYH is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.79, CYH is not doing good in the industry: 69.16% of the companies in the same industry are doing better.
The Debt to FCF ratio of CYH is 95.43, which is on the high side as it means it would take CYH, 95.43 years of fcf income to pay off all of its debts.
CYH has a Debt to FCF ratio of 95.43. This is comparable to the rest of the industry: CYH outperforms 50.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 95.43 | ||
| Altman-Z | 0.79 |
ROIC/WACC0.96
WACC5.9%
2.3 Liquidity
A Current Ratio of 1.41 indicates that CYH should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.41, CYH is in line with its industry, outperforming 45.79% of the companies in the same industry.
CYH has a Quick Ratio of 1.27. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.27, CYH perfoms like the industry average, outperforming 44.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.27 |
3. Growth
3.1 Past
CYH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.90%, which is quite impressive.
CYH shows a small growth in Revenue. In the last year, the Revenue has grown by 1.15%.
Measured over the past years, CYH shows a decrease in Revenue. The Revenue has been decreasing by -0.89% on average per year.
EPS 1Y (TTM)25.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.44%
Revenue 1Y (TTM)1.15%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%2.64%
3.2 Future
Based on estimates for the next years, CYH will show a very strong growth in Earnings Per Share. The EPS will grow by 39.52% on average per year.
Based on estimates for the next years, CYH will show a small growth in Revenue. The Revenue will grow by 2.91% on average per year.
EPS Next Y132.57%
EPS Next 2Y57.32%
EPS Next 3Y39.52%
EPS Next 5YN/A
Revenue Next Year1.75%
Revenue Next 2Y2.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CYH. In the last year negative earnings were reported.
CYH is valuated reasonably with a Price/Forward Earnings ratio of 10.46.
Based on the Price/Forward Earnings ratio, CYH is valued cheaply inside the industry as 88.78% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CYH to the average of the S&P500 Index (22.70), we can say CYH is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.46 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CYH indicates a somewhat cheap valuation: CYH is cheaper than 79.44% of the companies listed in the same industry.
100.00% of the companies in the same industry are more expensive than CYH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.06 | ||
| EV/EBITDA | 8.96 |
4.3 Compensation for Growth
CYH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CYH's earnings are expected to grow with 39.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y57.32%
EPS Next 3Y39.52%
5. Dividend
5.1 Amount
No dividends for CYH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.51
-0.03 (-0.85%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.45%
Inst Owner Change-94.32%
Ins Owners8.24%
Ins Owner Change-0.16%
Market Cap487.71M
Analysts70.77
Price Target4.51 (28.49%)
Short Float %10.16%
Short Ratio4.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-334.82%
Min EPS beat(2)-607.99%
Max EPS beat(2)-61.65%
EPS beat(4)1
Avg EPS beat(4)-173.72%
Min EPS beat(4)-607.99%
Max EPS beat(4)14.24%
EPS beat(8)2
Avg EPS beat(8)-216.6%
EPS beat(12)4
Avg EPS beat(12)-670.63%
EPS beat(16)8
Avg EPS beat(16)-238.58%
Revenue beat(2)1
Avg Revenue beat(2)0.95%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)2.67%
Revenue beat(4)3
Avg Revenue beat(4)0.8%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)2.67%
Revenue beat(8)4
Avg Revenue beat(8)0.51%
Revenue beat(12)4
Avg Revenue beat(12)-0.67%
Revenue beat(16)8
Avg Revenue beat(16)-0.22%
PT rev (1m)-7.7%
PT rev (3m)-15.43%
EPS NQ rev (1m)-13.57%
EPS NQ rev (3m)-13.57%
EPS NY rev (1m)1.82%
EPS NY rev (3m)-3.05%
Revenue NQ rev (1m)0.38%
Revenue NQ rev (3m)0.38%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 10.46 | ||
| P/S | 0.04 | ||
| P/FCF | 4.06 | ||
| P/OCF | 1.02 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.96 |
EPS(TTM)-1.03
EYN/A
EPS(NY)0.34
Fwd EY9.56%
FCF(TTM)0.86
FCFY24.6%
OCF(TTM)3.45
OCFY98.42%
SpS90.93
BVpS-13.77
TBVpS-41.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.66% | ||
| ROE | N/A | ||
| ROCE | 7.2% | ||
| ROIC | 5.69% | ||
| ROICexc | 5.71% | ||
| ROICexgc | 8.45% | ||
| OM | 6.67% | ||
| PM (TTM) | N/A | ||
| GM | 84.6% | ||
| FCFM | 0.95% |
ROA(3y)-1.43%
ROA(5y)0.09%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.27%
ROIC(5y)5.43%
ROICexc(3y)5.3%
ROICexc(5y)5.61%
ROICexgc(3y)7.93%
ROICexgc(5y)8.5%
ROCE(3y)6.68%
ROCE(5y)6.87%
ROICexcg growth 3Y-11.89%
ROICexcg growth 5Y0.9%
ROICexc growth 3Y-11.33%
ROICexc growth 5Y0.93%
OM growth 3Y-13.59%
OM growth 5Y-0.5%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y0.21%
F-Score5
Asset Turnover0.9
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 95.43 | ||
| Debt/EBITDA | 8.6 | ||
| Cap/Depr | 74.07% | ||
| Cap/Sales | 2.85% | ||
| Interest Coverage | 1.14 | ||
| Cash Conversion | 36.12% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 0.79 |
F-Score5
WACC5.9%
ROIC/WACC0.96
Cap/Depr(3y)81.42%
Cap/Depr(5y)81.99%
Cap/Sales(3y)3.33%
Cap/Sales(5y)3.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.44%
EPS Next Y132.57%
EPS Next 2Y57.32%
EPS Next 3Y39.52%
EPS Next 5YN/A
Revenue 1Y (TTM)1.15%
Revenue growth 3Y0.71%
Revenue growth 5Y-0.89%
Sales Q2Q%2.64%
Revenue Next Year1.75%
Revenue Next 2Y2.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.99%
EBIT growth 3Y-12.97%
EBIT growth 5Y-1.39%
EBIT Next Year66.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y146.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y128.57%
OCF growth 3YN/A
OCF growth 5Y4.51%